The expression level of FOXO1 was lower in the CAD group than in the control group (26.51 ± 14.46 vs. 31.74 ± 27.42 ng/L, respectively), but the difference was not statistically significant (P = 0.36). The gene discussed is FOXO1; the disease is coronary artery disorder.